Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 13.246\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) COc1cccc(/C=N/Nc2nnc(C)n2N)c1O.Cl
b) COc1ccc(C2=NOC(C(=O)NCc3cccnc3)C2)cc1OC
c) CC(CC(=O)Nc1ccc2c(c1)OCO2)c1ccccc1
d) Cc1c(NC(=O)CSc2nccn2C)c(=O)n(-c2ccccc2)n1C
Answer: d. Cc1c(NC(=O)CSc2nccn2C)c(=O)n(-c2ccccc2)n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1c(NC(=O)CSc2nccn2C)c(=O)n(-c2ccccc2)n1C
Cc1c(NC(=O)CSc2nccn2C)c(=O)n(-c2ccccc2)n1C
N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-2-(1-methylimidazol-2-yl)sulfanylacetamide